期刊文献+

以草酸铂为主的联合化疗方案治疗晚期胃癌的临床观察

The Curative Effect of Combined Chemotherapy Mainly Using Oxaliplatin on Advanced Gastric Cancer
下载PDF
导出
摘要 目的观察草酸铂(L-OHP)联合氟脲嘧啶(5-Fu)、甲酰四氢叶酸钙(CF)和羟基喜树碱(HCPT)治疗晚期胃癌41例的疗效。方法用L-OHP 85 mg/m^2加于葡萄糖注射液中静滴2 h,d1,15;CF 150 mg/m^2静脉滴注,d1,15(输注5-Fu前用药);5-Fu 400 mg/m^2静脉推注,d1,15,5-Fu 2.4-3.0 g便携式微泵帮注入(Civ)48 h,d1,15,HCPT6 mg/m2静脉滴注,d1-5,每30 d为1周期,2周期评价疗效。结果本方案总有效率为56.1%,中位缓解期为8.5个月,中位生存期为10.4个月。并发症以周围神经毒性为主,恶心、呕吐反应轻,Ⅳ度骨髓抑制少。结论L-OHP联合CF、5-Fu和HCPT方案治疗晚期胃癌,疗效好、毒副反应轻、耐受性好,值得进一步临床推广应用。 Objective To observe the curative effect of combined chemotherapy using oxaliplatin, lencovorin, 5-fluorotiracil, and hyclroxycamptothecine, on advanced gastric cancer. Methods This mixture was put into dextrose injection liquor, 85 mg/m^2 L-OHP was mainlined for 2 hours,d1.15 ; 150 mg/m^2 CF was mainlined, d1.15 ; 400 mg/m^2 5-Fu was injected via vein ,d1.15 ; 2.4 -3.0 g 5-Fu was pumped by portable micro-pump for 48 hours, d1.15 ; 6 mg/m^2 HCPT was mainlined, d1-5^* One cycle was 30 days, and the curative effect was evaluated after 2 cycles. Results 56.1% patients had curative effects. The average period of relife was 8.5 months, and the average period of survival was 10.4 months. The therapy caused toxicity on peripheral nerve, mild retching, and little Ⅳ inhibition on bone marrow. Conclusion This combined chemotherapy was worthy of being extended in clinic, for it had good curative effect on advanced gastric cancer, though with some mild side effect.
机构地区 丹阳市中医院
出处 《肿瘤基础与临床》 2007年第3期246-247,共2页 journal of basic and clinical oncology
关键词 草酸铂 联合化疗 晚期胃癌 oxaliplatin combined chemotherapy advanced gastric cancer
  • 相关文献

参考文献4

二级参考文献32

  • 1金懋林.中国临床肿瘤学教育专辑[M].北京:中国医药科技出版社,2000.143-154.
  • 2[1]Alberts SR, Cervantes A, van de Velde CJH. Gastric cancer:Epidemiology, pathology and treatment. Annals of Oncology,2003, 14 (Suppl 2) :ii31
  • 3[2]Frederick LG, David LP, Irvin DF, et al. AJCC Cancer Staging Manual. 6th. ed, New York: Springer, 2002, 99
  • 4[3]Hundahl SA, Menck HR, Mansour EG, et al. The national cancer database report on gastric carcinoma. Cancer, 1997, 80: 2333
  • 5[4]Spataro V, Genoni M, Maurer C, et al. Stomach cancer: 10years' experience with surgical treatment and possibilities for improving the prognosis. Helv Chir Acta, 1993, 59:589
  • 6[5]Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med, 2001, 345:725
  • 7[6]Bajetta E, Buzzoni R, Mariani E, et al. Adjuvant chemotherapy in gastric cancer: 5 - year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Annals of Oncology, 2002, 13:299
  • 8[7]Falcone A. Future strategies and adjuvant treatment of gastric cancer. Annals of Oncology, 2003, 14 (Suppl 2) :ii45
  • 9[8]Roth AD, Allal AS, Brundler MA, et al. Neoadjuvant radiochemotherapy for locally advanced gastric cancer: A phase Ⅰ -Ⅱ study. Annals of Oncology, 2003, 14:110
  • 10[9]Newman E, Marcus SG, Potmesil M, et al. Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer. J Gastrointest Surg, 2002 6 (2) :212 (discussion 223)

共引文献466

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部